Navigation Links
Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/7/2012

CARLSBAD, Calif., Nov. 07, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 2:00 p.m. ET in New York, NY. 

A live audio webcast of the presentation and panel will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

Forward-Looking Statements
This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
2. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
4. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Thom Rowland Joins Arbor Pharmaceuticals as Vice President of Commercial Operations
8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
9. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
10. Cadence Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Neuralstem, Inc. (NYSE MKT: CUR), a ... small molecule and cell therapy treatments for central nervous ... Jones to the position of Chief Financial Officer, ... Lloyd Jones brings to the position more ... experience.   Most recently, Mr. Lloyd Jones served ...
(Date:5/6/2015)... 2015 AbbVie (NYSE: ABBV ) will ... Health Care Conference on Wednesday, May 13, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:5/6/2015)... , May 6, 2015   Symbiomix Therapeutics ... the third and final tranche of a $41 million ... randomized Phase 2 trial testing a single oral dose ... Based on discussions with the U.S. Food and Drug ... now is planning to submit the Phase 2 trial ...
Breaking Medicine Technology:Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5
(Date:5/6/2015)... Jose, California (PRWEB) May 06, 2015 ... of hand sanitizers are increasing, driven by the rising ... preventing the spread of contagious diseases. Hand washing is ... result of consumer apprehension over contracting infections. Periodic outbreak ... as the recent Ebola virus disease (EVD) ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, ... as having one the best Extra Virgin Olive Oils in ... region of Greece and known as Laconiko , received ... Medium Olive Oil, which is defined by the competition as ... 700 producer applicants from 25 different countries applying, Laconiko stood ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 Topical BioMedics, ... on Tuesday, May 12th, from 12pm – 1pm, streamed live ... is free and open to the public by clicking on ... questions from attendees are invited “real time” during the webinar, ... pmartin(at)topicalbiomedics(dot)com. , The topic for the May ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 On ... Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, ... providers of products and services that maintain ecologically ... Durkin, Los Angeles’ leading producer of TV and ... is a premier red carpet event that makes ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com ... will give away a deluxe human hair lace wig valued ... to enter on a third-party giveaway tool. The important thing ... be the winner. , The hair is a crown, a ... for such a jewel for the past 20 years. Whether ...
Breaking Medicine News(10 mins):Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2
... to wash their handsDALLAS, May 12 Parents worried about ... washing their hands enough finally have some help. Two parents ... often thought the reason might be that their kids didn,t ... Soap Labs LLC, a unique device that gets kids to ...
... Johnson (NYSE: JNJ ) will host a conference ... May 19, 2009 to review the primary data from NEVO ... Coronary Stent. NEVO(TM) is the first and only drug-eluting stent ... Results from this trial will support a design dossier submission ...
... of an effort to make high-precision particle cancer therapy ... Department of Energy,s (DOE) Brookhaven National Laboratory has developed ... beams. Brookhaven Science Associates, the company that manages the ... patent on the design, which is now available for ...
... study in rats at the University of Haifa reveals:,Trauma ... her offspring,s behavior. , *"The findings show that trauma ... her pregnancy, will affect her offspring,s emotional and social ... humans too," stated Prof. Micah Leshem who carried out ...
... Members Better Manage Healthcare Needs and Spending , ... Company of America (Guardian), one of the largest mutual life ... for small and mid-sized companies, today introduced enhanced Wellness features ... will now have access to a broad range of resources ...
... families caring for seniors to screen ground-breaking documentary series ... SRZ ) communities will host special screenings ... to encourage greater awareness about the disease as well ... a local Sunrise community by going to ...
Cached Medicine News:Health News:Flashing Lights Help Kids Avoid the Swine Flu 2Health News:Compact cancer-therapy particle-delivery system patented 2Health News:Trauma experienced by a mother even before pregnancy will influence her offspring's behavior 2Health News:Guardian Enhances Medical Plans With New Wellness Benefits 2Health News:Guardian Enhances Medical Plans With New Wellness Benefits 3Health News:Guardian Enhances Medical Plans With New Wellness Benefits 4Health News:Sunrise Senior Living Communities to Show HBO's The Alzheimer's Project 2Health News:Sunrise Senior Living Communities to Show HBO's The Alzheimer's Project 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: